Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Product - Sentynl Therapeutics, |
Description | Our You are using an outdated browser. Please upgrade your browser to improve your experience and security. Sentynl Therapeutics, Inc. Our Focus About Us Lead |
Keywords | N/A |
WebSite | origintx.com |
Host IP | 40.71.11.146 |
Location | United States |
Site | Rank |
US$1,592
Last updated: 2023-05-12 20:31:09
origintx.com has Semrush global rank of 0. origintx.com has an estimated worth of US$ 1,592, based on its estimated Ads revenue. origintx.com receives approximately 183 unique visitors each day. Its web server is located in United States, with IP address 40.71.11.146. According to SiteAdvisor, origintx.com is safe to visit. |
Purchase/Sale Value | US$1,592 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$44 |
Yearly Ads Revenue | US$529 |
Daily Unique Visitors | 12 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
origintx.com. | A | 599 | IP: 40.71.11.146 |
origintx.com. | NS | 3600 | NS Record: ns59.domaincontrol.com. |
origintx.com. | NS | 3600 | NS Record: ns60.domaincontrol.com. |
origintx.com. | MX | 600 | MX Record: 10 origintx-com.mail.protection.outlook.com. |
origintx.com. | TXT | 600 | TXT Record: docusign=2c6ad9a4-cb51-41c6-932f-dba4084e81c7 |
origintx.com. | TXT | 600 | TXT Record: ZOOM_verify_3lC1XaLsSkSLGCuBqsWuHQ |
origintx.com. | TXT | 600 | TXT Record: smartsheet-site-validation=Ha6gRnb08KZlP5M2OH2EyvGsjZpLXhWo |
origintx.com. | TXT | 600 | TXT Record: atlassian-domain-verification=1B0VBZowCwrHaNRCkw7sDkV1xZVrb1pXXnwKWOH58wRAmZzCRNdGJmLfm5/3mPnn |
origintx.com. | TXT | 600 | TXT Record: ppe-d71b945f8b1e28ac26e1 |
origintx.com. | TXT | 600 | TXT Record: h42cgfgf6qlgnqq3uc1bf9cuqf |
origintx.com. | TXT | 600 | TXT Record: v=spf1 include:mailgun.org include:_spf.psm.knowbe4.com include:spf.protection.outlook.com a:dispatch-us.ppe-hosted.com ~all |
origintx.com. | TXT | 600 | TXT Record: MS=ms43749050 |
origintx.com. | TXT | 600 | TXT Record: knowbe4-site-verification=621770f29dd02324b411b937da52b3c3 |
origintx.com. | TXT | 600 | TXT Record: MS=ms65793833 |
origintx.com. | TXT | 600 | TXT Record: adobe-idp-site-verification=701ea73bf0276d85d469dd4fcbf9bb6f9df52a5b4f70277c24573308ed348be6 |
origintx.com. | TXT | 600 | TXT Record: ppe-8f7ad08cdf9d3759d5d5acc27a725f2282f1e73d |
You are using an outdated browser. Please upgrade your browser to improve your experience and security. Sentynl Therapeutics, Inc. Our Focus About Us Leadership Compliance Rare Disease Portfolio Portfolio Patient Support Sentynl Cares Work With Us Business Development Careers News and Events Contact Terms of Use Privacy Accessibility Product Safety Our Product Portfolio Approved US Product This product information is intended for US audiences only. For residents outside the US, click here for more information on early access to Nulibry. Nulibry® (fosdenopterin) for injection, for intravenous use What is NULIBRY? NULIBRY is indicated to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A. 1 It is a cyclic pyranopterin monophosphate (cPMP) that replaces a critical component the body needs to make molybdenum cofactor (MoCo). To learn more, visit nulibry.com . What is MoCD Type A? MoCD Type A is a rare and devastating inborn error of metabolism (IEM) |
HTTP/1.1 301 Moved Permanently Content-Length: 0 Content-Type: text/html; charset=UTF-8 Location: https://origintx.com/ Date: Mon, 20 Dec 2021 00:03:14 GMT HTTP/1.1 301 Moved Permanently Content-Length: 0 Content-Type: text/html; charset=iso-8859-1 Location: https://www.origintx.com/ Server: Apache Date: Mon, 20 Dec 2021 00:03:14 GMT HTTP/1.1 200 OK Content-Length: 20631 Content-Type: text/html Last-Modified: Thu, 16 Sep 2021 17:19:04 GMT Accept-Ranges: bytes ETag: "5097-5cc2002f23200" Vary: Accept-Encoding Server: Apache Date: Mon, 20 Dec 2021 00:03:14 GMT |
Domain Name: ORIGINTX.COM Registry Domain ID: 2238560542_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-05-18T20:00:45Z Creation Date: 2018-03-13T16:11:07Z Registry Expiry Date: 2022-03-13T16:11:07Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS59.DOMAINCONTROL.COM Name Server: NS60.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T08:41:08Z <<< |